Adlyxin and Soliqua Join a Crowded Market of Injectable Diabetes Meds

January 2017

Adlyxin (ad-LIKS-in) and Soliqua (soh-LEE-kwa) will be two new once-daily injectable meds for type 2 diabetes....

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscription Options

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

OTC Products Help Patients Prevent Overdoses and Mix-Ups With OTCs
Insurance Prioritize Urgent Prior Auth Requests to Avoid Gaps in Therapy
Diabetes Adlyxin and Soliqua Join a Crowded Market of Injectable Diabetes Meds
End of Life Care Help With Unique End-of-Life Med Considerations
Obesity Weight Loss Lomaira and Belviq XR Are New C-IV Meds for Weight Loss
Opioids Be Ready to Help More Patients Use Buprenorphine/Naloxone for Opioid Dependence
Calcium Send Patients With Questions About Calcium Supplements to the Pharmacist
Acne Help Patients Use New OTC Differin 0.1% Acne Gel Safely
Vaccines Expect Pregnant Women to Get Tdap Vaccine With Every Pregnancy
Dehydration Help Sort Through Options for Managing Dehydration in Kids
Inhalers Help Prevent Common Inhaler Errors